CellCOM
![Foto de CellCOM](/img/grupo.png)
![Foto de Hospital Sagrado Corazón](/img/noimage_org.png)
Hospital Sagrado Corazón
Barcelona, EspañaPublicacións en colaboración con investigadores/as de Hospital Sagrado Corazón (3)
2014
2013
2011
-
Clinical characteristics and disease course in patients treated with efalizumab following suspension of marketing authorization by the European Medicines Agency: A multicenter observational study
Actas Dermo-Sifiliograficas, Vol. 102, Núm. 5, pp. 354-364